FDA NDC Directory · JSON-LD · Markdown

Sarclisa

NDC 0024-0656 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameisatuximab
Labeler / ManufacturerSanofi-Aventis U.S. LLC
Marketing categoryBiologic License Application · App BLA761113
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsISATUXIMAB (500 mg/25mL)
Marketing started20200302
Package count1

External sources

Source: openFDA. Public-domain (CC0).